MedTrace Logo

A Study of CAR-T Cells Targeting Autoimmune Diseases

NCT06661811 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-10-28

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in patients with autoimmune disease.

Conditions

Interventions

DRUG

CAR-T

CAR-T cells

Sponsors & Collaborators

  • Beijing Boren Hospital

    lead OTHER

Principal Investigators

  • Yajing Zhang, MD/PhD · Beijing Gaobo Boren Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-15
Primary Completion
2028-04-20
Completion
2028-06-20

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06661811 on ClinicalTrials.gov